* The US Food and Drug Administration on Wednesday, April 1st 2020 granted Emergency Use Authorization (EUA) to Ipsum Diagnostics for the company’s RT-PCR-based SARS-CoV-2 test. The FDA EUA increased our testing capacity processing from 1000 to 4000 tests per day.

Total Reported: 587,000+


0.5 Days

Please email our courier service department for fast and reliable specimen pickup and transfer.



Ipsum Diagnostics, LLC, or other laboratories designated by Ipsum Diagnostics, LLC that are also certified under the ClinicalLaboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C.§263a,

Read More »